12,372 trials
Urinary Incontinence, Stress
Primary: Percentage of Participants With Response (Based on Stress IEF, or In-office Pad Weight Test, or 24-hour Pad Weight Test) at 12 Months — 82; 90 Percentage of subjects
Asthma
Primary: Percent Change From Baseline in the Final Daily, Average, OCS Dose at Week 40 While Not Losing Asthma Control. — -37.62; -29.85 Percent change from baseline — p=0.271
Malaria, Vivax
Primary: Percentage of Participants With Clinically Relevant Hemolysis. — 2.41; 1.18 Percentage of participants
Coronary Artery Disease
Primary: Presence of a Myocardial Perfusion Defect Indicating Significant CAD Per Participant on Gadobutrol-enhanced CMRI (Based on RPS) - Primary Analysis of Sensitivity Based…
Coronary Artery Disease
Primary: Presence of a Myocardial Perfusion Defect Indicating Significant CAD Per Participant on Gadobutrol-enhanced CMRI - Primary Analysis of Sensitivity Based on Blinded…
Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Primary: Percentage of Subjects Achieved Freedom From Atrial Tachyarrhythmias — 60.6; 60.8; 60 Percentage of participants
Good Prognosis Metastatic Gestational Trophoblastic Tumor · Hydatidiform Mole · Non-Metastatic Gestational Trophoblastic Tumor
Primary: Response Based on Blood Human Chorionic Gonadotropin (hCG) Assay — 57; 76; 48; 29 Participants
Cat Allergy
Primary: Mean Combined Score (CS) Consisting of TRSS/8+Allergy Medication Score[AMS]) — 1.99; 1.91; 1.93 units on a scale
Hemophilia A
Primary: Global Hemostatic Efficacy Assessment Score (GHEA) - Composed of 3 Individual Ratings — 100.0; 100.0; 100.0; 100.0 Percentage of surgeries
Rhinoconjunctivitis
Primary: Mean Combined Score in Cat-PAD Treatment Groups Compared With Placebo — 1.04; 1.00; 1.05 units on a scale
Familial Hypercholesterolemia
Primary: Percent Change in Low Density Lipoprotein Cholesterol (LDL-C) — -45.5 Percent Change
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Hemoglobin A1C (A1C) at Week 52: Excluding Rescue Approach — -0.56; -0.64; -0.74 Percent
Nausea · Vomiting
Primary: Occurrence of Intra-operative and Post-operative Vomiting — 30; 45 Participants — p=0.07
Hematological Malignancies
Primary: Percentage Change in Bone Mineral Density From Baseline to 6 and 12 Months — 0.06; -2.61; -3.63; -4.85 Percentage change
Exocrine Pancreatic Insufficiency · Cystic Fibrosis
Primary: Safety — 3; 0 Participants